This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n15http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/iuphar/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/guide-to-pharmacology/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/bindingdb/
n18http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/kegg-compound/
n19http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n16http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/resource/drugbank/drug/DB02517/identifier/pubchem-substance/

Statements

Subject Item
n2:DB02517
rdf:type
n3:Drug
n3:description
A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the central nervous system. [PubChem]
n3:group
experimental
owl:sameAs
n6:DB02517 n11:DB02517
dcterms:title
D-Glutamic Acid
adms:identifier
n8:15966 n9:591 n12:26431 n13:1369 n14:1369 n15:DB02517 n16:33032 n17:46508281 n18:C00217 n19:DGL
n3:synthesisReference
Toshiyuki Hamaoka, Kayoko Tateishi, "Producing highly specific, low cross-reactive antibody by immunizing with copolymer of D-glutamic acid and lysine." U.S. Patent US4722899, issued June, 1985.
n3:IUPAC-Name
n4:271B3E72-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3E78-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3E77-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3E74-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3E75-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3E76-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3E70-363D-11E5-9242-09173F13E4C5 n4:271B3E88-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B657E-363D-11E5-9242-09173F13E4C5 n4:271B3E71-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B657F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3E7E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3E7F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3E79-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3E7A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3E7C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3E7B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3E7D-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
6893-26-1
n3:Bioavailability
n4:271B3E84-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3E86-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3E87-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B3E89-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3E83-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3E82-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3E85-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3E73-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3E80-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3E81-363D-11E5-9242-09173F13E4C5